Telcagepant provides new hope for people with migraine
(2009) In Nature Reviews Neurology 5(5). p.240-242- Abstract
- The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1426330
- author
- Edvinsson, Lars LU
- organization
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Reviews Neurology
- volume
- 5
- issue
- 5
- pages
- 240 - 242
- publisher
- Nature Publishing Group
- external identifiers
-
- wos:000265854700002
- scopus:68349089395
- ISSN
- 1759-4766
- DOI
- 10.1038/nrneurol.2009.49
- language
- English
- LU publication?
- yes
- id
- bcd6b8d2-8cdc-4a80-b5ba-9901aca2daa0 (old id 1426330)
- date added to LUP
- 2016-04-01 11:45:29
- date last changed
- 2024-01-07 19:23:20
@misc{bcd6b8d2-8cdc-4a80-b5ba-9901aca2daa0,
abstract = {{The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.}},
author = {{Edvinsson, Lars}},
issn = {{1759-4766}},
language = {{eng}},
number = {{5}},
pages = {{240--242}},
publisher = {{Nature Publishing Group}},
series = {{Nature Reviews Neurology}},
title = {{Telcagepant provides new hope for people with migraine}},
url = {{http://dx.doi.org/10.1038/nrneurol.2009.49}},
doi = {{10.1038/nrneurol.2009.49}},
volume = {{5}},
year = {{2009}},
}